OTCMKTS:BITGF Biotage AB (publ) (BITGF) Stock Price, News & Analysis $15.01 0.00 (0.00%) As of 07/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Biotage AB (publ) Stock (OTCMKTS:BITGF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Biotage AB (publ) alerts:Sign Up Key Stats Today's Range$15.01▼$15.0150-Day Range$15.01▼$15.0152-Week Range$8.77▼$18.52VolumeN/AAverage Volume1,212 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Biotage AB (publ) is a Sweden‐based provider of advanced instrumentation and consumables for analytical and synthetic chemistry. The company’s product portfolio spans automated flash purification systems, sample preparation solutions, microwave reactors and peptide synthesizers, as well as associated reagents and software. By integrating instrumentation with tailored chemistry workflows, Biotage addresses the needs of pharmaceutical, biotechnology, agrochemical and environmental laboratories seeking to accelerate drug discovery, streamline process development and enhance analytical throughput. Within its analytical chemistry offering, Biotage supplies flash and preparative chromatography systems, evaporators and solid‐phase extraction devices designed to improve sample purity and detection sensitivity. In the synthetic chemistry arena, the company’s microwave synthesis platforms and peptide synthesizers enable researchers to perform rapid method development and scale‐up reactions with precise control of temperature and reaction parameters. Biotage also provides a range of specialty resins, columns and cartridges that support applications from small‐molecule purification to complex biomolecule production. Headquartered in Uppsala, Sweden, Biotage operates a global network of regional offices, application laboratories and manufacturing sites across Europe, North America and Asia Pacific. The company was formed through the consolidation of specialty chemistry divisions in the late 1990s and later rebranded to Biotage AB in 2008, reflecting its broadened focus on life science and industrial markets. Biotage’s solutions are utilized by academic institutions, contract research organizations and multinational corporations seeking to optimize workflows from early‐stage discovery through commercial production.AI Generated. May Contain Errors. Read More Receive BITGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotage AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BITGF Stock News HeadlinesBITGF Biotage AB (publ)June 5, 2025 | seekingalpha.comKKR offers to buy Biotage for SEK 145 per share in cashApril 23, 2025 | markets.businessinsider.comBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. | Chaikin Analytics (Ad)European Stocks That May Be Trading Below Their Estimated Intrinsic ValueFebruary 27, 2025 | finance.yahoo.comBiotage AB (publ) (BITGF)January 30, 2025 | ca.finance.yahoo.comUncover These 3 Undiscovered Gems with Promising PotentialNovember 22, 2024 | finance.yahoo.comBiotage AB: Biotage AB appointment of new CEOAugust 14, 2024 | finanznachrichten.deKKR mulls sale of 17% stake in Swedish life sciences firm Biotage - reportJuly 19, 2024 | msn.comSee More Headlines BITGF Stock Analysis - Frequently Asked Questions How have BITGF shares performed this year? Biotage AB (publ)'s stock was trading at $15.0145 at the beginning of the year. Since then, BITGF shares have increased by 0.0% and is now trading at $15.0145. How do I buy shares of Biotage AB (publ)? Shares of BITGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:BITGF CIKN/A Webwww.biotage.com Phone46 18 56 59 00FaxN/AEmployees669Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:BITGF) was last updated on 7/6/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredBuy the “unseen winner of the AI race” before July 22Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split...Chaikin Analytics | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredElon Musk on His New Invention: “An Infinite Money Glitch.”Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's ...Brownstone Research | SponsoredThey proved it worked in '76. Then buried it.In 1976, Chevron, Unocal, and Texaco each confirmed the same energy technology worked - no fuel costs, no carb...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotage AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotage AB (publ) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.